A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.

Clinical trial NCT07362459 · RECRUITING

Trial details

NCT number: NCT07362459
Sponsor: Sinocelltech Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Carcinoma (NSCLC)

Start date: 2025-12-30
Primary completion: 2027-07-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.